High-dose ara-C in older adults with acute leukemia

Leukemia

Volumn 10, Issue SUPPL. 1, 1996, Pages

  Herzig, Roger H ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

Acute leukemia; HIDAC; High dose ara C

Indexed keywords

CYTARABINE; IDARUBICIN;

ACUTE LEUKEMIA; ADULT; AGED; BLOOD TOXICITY; CONFERENCE PAPER; DIARRHEA; GASTROINTESTINAL TOXICITY; HUMAN; NEUROTOXICITY; PRIORITY JOURNAL; SKIN TOXICITY;

EID: 0029919719     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Baer MR, Herzig GP. Personal communication.
2. Herzig RH, Hines JD, Herzig GP, Wolff SN, Cassileth PA, Lazarus HM, Adelstein DJ, Brown RA, Coccia PF, Strandjord S, Mazza JJ, Fay J, Philips GL. Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol 1987; 5: 927-932.
3. Herzig RH, Lazarus HM, Wolff SN, Philips GL, Herzig GP. High-dose cytosine arabinoside therapy with and without anthracyclinc antibiotics for remission reinduction of acute nonlymphoblastic leukemia. J Clin Oncol 1985; 3: 992-997.
4. Herzig RH, Wolff SN, Lazarus HM, Philips GL, Karanes C, Herzig GP. High-dose cytosine arabinoside in the successful treatment of refractory leukemia. Blood 1983; 62: 361-369.
5. Lazarus HM, Herzig RH, Herzig GP, Philips GL, Roessmann U, Fishman DJ. Central nervous system toxicity of high-dose systemic cytosine arabinoside. Cancer 1981; 48: 2577-2583.
6. Nand S, Messmore HL, Patel R, Fisher SG, Fisher RI. Neurotoxicity associated with systemic high-dose cytosine arabinoside. J Clin Oncol 1986; 4: 571-575.
7. Preisler HD, Raza A, Barcos M, Azarnia N, Larson R, Walker I, Browman M, Grunwals H, D'Arrigo P, Doeblin T, Stein A, Logue G, Goldberg J, Kirshner J, Gottlieb A, Bennett J. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup study. J Clin Oncol 1987; 5: 75-82.
8. Shepherd JD, Reece DE, Klingemann HG, Barnett MJ, Phillips GL. Acute myeloid leukemia (AML) in patients (pts) over 60: induction and consolidation therapy with moderate-dose cytosine arabinoside, mitoxantrone, and etoposide (abstract). Haematologica 1991; 76: 90 and Proc Amer Soc Clin Oncol 1991; 10: 772a (abstract).
9. Shepherd JD, Reece DE, Klingemann HG, Barnett MJ, Phillips GL. Acute myeloid leukemia (AML) in patients (pts) over 60: induction and consolidation therapy with moderate-dose cytosine arabinoside, mitoxantrone, and etoposide (abstract). Haematologica 1991; 76: 90 and Proc Amer Soc Clin Oncol 1991; 10: 772a (abstract).
10. Weick RH, Kopecky KJ, Appelbaum FR, Head DR, Kingsbury LL, Balcerzak SP, Mills GM, Hynes HE, Welborn JL, Simon SR, Grever M. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia. Submitted for publication, 1995.